BioCentury | Apr 24, 2020
Finance

Big gain for ORIC in trading debut after pricing upsized IPO

...a second oncology program, ORIC-533, which targets CD73. ORIC’s largest shareholders are The Column Group, Topspin Partners...
BioCentury | Aug 9, 2019
Financial News

ORIC raises $55M to fund trials in drug-resistant cancers

...investors Hartford HealthCare Endowment and Casdin Capital participated, as did existing investors The Column Group, TopSpin Partners...
BioCentury | May 21, 2019
Company News

Merck bets on HIF2As with Peloton takeout ahead of planned listing

...a 19.6% stake, The Column Group is Peloton's largest shareholder. Remeditex has a 14.7% stake, Topspin Partners...
BioCentury | Apr 26, 2019
Financial News

Schizophrenia therapy developer Karuna among four biotechs to file for IPOs

...investors with more than a 5% stake in Peloton are The Column Group, Remeditex Ventures, Topspin Partners...
BioCentury | Jul 20, 2018
Financial News

Constellation raises $60M in NASDAQ IPO

...include The Column Group, Third Rock Ventures, Venrock, the Regents of the University of California, Topspin Partners...
BioCentury | Jul 19, 2018
Financial News

Constellation slips after pricing $60M IPO

...include The Column Group, Third Rock Ventures, Venrock, the Regents of the University of California, Topspin Partners...
BioCentury | Jun 23, 2018
Financial News

Latest batch of IPO filings: Rubius, Constellation, Replimune, Allakos

...22%), Third Rock Ventures (13%), Venrock (11%), the Regents of the University of California (10%), Topspin Partners...
BioCentury | Apr 13, 2018
Financial News

Constellation raises $100M

...investors The Column Group, Third Rock Ventures, Venrock, SR One, University of California Investment Office, Topspin Partners...
BioCentury | Apr 9, 2018
Financial News

Constellation raises $100M venture round

...investors The Column Group, Third Rock Ventures, Venrock, SR One, University of California Investment Office, Topspin Partners...
BioCentury | Apr 9, 2018
Finance

Epigenetic experience

...The Column Group, Third Rock Ventures, Venrock, SR One, the University of California Investment Office, Topspin Partners...
Items per page:
1 - 10 of 33
BioCentury | Apr 24, 2020
Finance

Big gain for ORIC in trading debut after pricing upsized IPO

...a second oncology program, ORIC-533, which targets CD73. ORIC’s largest shareholders are The Column Group, Topspin Partners...
BioCentury | Aug 9, 2019
Financial News

ORIC raises $55M to fund trials in drug-resistant cancers

...investors Hartford HealthCare Endowment and Casdin Capital participated, as did existing investors The Column Group, TopSpin Partners...
BioCentury | May 21, 2019
Company News

Merck bets on HIF2As with Peloton takeout ahead of planned listing

...a 19.6% stake, The Column Group is Peloton's largest shareholder. Remeditex has a 14.7% stake, Topspin Partners...
BioCentury | Apr 26, 2019
Financial News

Schizophrenia therapy developer Karuna among four biotechs to file for IPOs

...investors with more than a 5% stake in Peloton are The Column Group, Remeditex Ventures, Topspin Partners...
BioCentury | Jul 20, 2018
Financial News

Constellation raises $60M in NASDAQ IPO

...include The Column Group, Third Rock Ventures, Venrock, the Regents of the University of California, Topspin Partners...
BioCentury | Jul 19, 2018
Financial News

Constellation slips after pricing $60M IPO

...include The Column Group, Third Rock Ventures, Venrock, the Regents of the University of California, Topspin Partners...
BioCentury | Jun 23, 2018
Financial News

Latest batch of IPO filings: Rubius, Constellation, Replimune, Allakos

...22%), Third Rock Ventures (13%), Venrock (11%), the Regents of the University of California (10%), Topspin Partners...
BioCentury | Apr 13, 2018
Financial News

Constellation raises $100M

...investors The Column Group, Third Rock Ventures, Venrock, SR One, University of California Investment Office, Topspin Partners...
BioCentury | Apr 9, 2018
Financial News

Constellation raises $100M venture round

...investors The Column Group, Third Rock Ventures, Venrock, SR One, University of California Investment Office, Topspin Partners...
BioCentury | Apr 9, 2018
Finance

Epigenetic experience

...The Column Group, Third Rock Ventures, Venrock, SR One, the University of California Investment Office, Topspin Partners...
Items per page:
1 - 10 of 33